Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

hiv_aids

The global HIV/AIDS movement

November 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AIDS, HIV, International HIV/AIDS Alliance

Increasingly collaborative efforts have seen the threat of HIV recede and brought hope to demographics and communities most vulnerable to …
Feature

Bayer’s $175 million pneumonia drug fails at phase 3

November 27, 2017 Research and Development, Sales and Marketing Amikacin, Amikacin Inhale, Bayer, Nektar Therapeutics, pharma

Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …
News
shutterstock_138095450

Proposed cuts to National Institutes of Health could delay up to 90% of US drug approvals

November 27, 2017 Research and Development, Sales and Marketing Donald Trump, FDA, NIH, National Institutes of Health, Trump, pharma

President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

As Friday comes round again, this week saw some of the biggest news of the year: Amsterdam is the new …
News
crowd-2045498_960_720

Different gene mutations in multiple myeloma depending on ancestry

November 24, 2017 Medical Communications, Research and Development biotech, drugs, multiple myeloma, pharma, pharmaceutical

Researchers, based in the US, have conducted a large-scale collection of publicly available data and found that significant differences can …
News
astrazeneca_sign_sky

AZ partners with Combinations Alliance to test drug in cancer

November 24, 2017 Medical Communications, Research and Development AstraZeneca, biotech, drugs, pharma, pharmaceutical

A clinical trial is to be launched to test AstraZeneca’s experimental drug, AZD1775, for the treatment of head and neck …
News
640px-hiv-budding-color

Learning lessons from HIV to change the treatment access landscape

November 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, pharma

Greg Alton, Executive Vice President of Corporate and Medical Affairs at Gilead, reveals how the rapid development and distribution of …
Feature
online_survey_icon_or_logo_v2

Collaboration in Biopharma

November 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague, Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological …
News
aedes_aegypti_mosquito

Budget cuts to the President’s Malaria Initiative could risk 67 million lives, report finds

November 22, 2017 Medical Communications, Research and Development Africa, Trump, USA, WHO, malaria, pharma

A team of researchers at Imperial College London (ICL) has argued that the proposal by US Congress to cut the …
News
brain-770044_960_720

‘Brain training’ found to reduce risk of dementia by 29%

November 22, 2017 Research and Development biotech, dementia, drugs, pharma, pharmaceutical

In a 10-year study conducted at the Indiana University School of Medicine, researchers were able to observe a 29% reduced …
News
gsk_boronia_australia

FDA approves first-ever two-drug HIV regimen, GSK’s Juluca

November 22, 2017 Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma

GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …
News
addict-2713526_960_720

EU approves opioid treatment, amid fears of US-like crisis

November 22, 2017 Research and Development, Sales and Marketing Zubsolv, biotech, drugs, opioid, orexo, pharma, pharmaceutical

The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …
News
promotional_banner

Free Webinar: The End Game – Payer Engagement

November 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
News

Boehringer offers its molecules to the scientific community via new platform

November 21, 2017 Manufacturing and Production, Research and Development Boehringer Ingelheim, pharma

Boehringer Ingelheim has unveiled opnME.com, a centralised platform which makes available selected pre-clinical molecules from its portfolio for free, accessible …
News
shutterstock_187433765

Obesity leads to larger, harder-to-detect tumours in breast cancer, study finds

November 21, 2017 Manufacturing and Production, Research and Development Cancer, breast cancer, pharma

A study from Sweden’s Karolinska Institute has indicated that cancerous tumours in overweight women are likely to be larger and …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025